Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FBXW7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC41A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD99P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
LOC102724364 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA0141 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LZTS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLCN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCTD15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TYSND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACAD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP98 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM110 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL42 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on